Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOSUND ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   12.8% 10.4% 6.4% 9.3% 8.9% 14.4% 21.1% 21.1%   Credit score (0-100)   19 25 37 25 27 14 5 5   Credit rating   BB BB BBB BB BB BB B B   Credit limit (kDKK)   -0.0 -0.0 0.0 -0.0 0.0 -0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -216 -139 320 -506 115 -170 0.0 0.0   EBITDA   -216 -139 320 -506 115 -170 0.0 0.0   EBIT   -216 -142 282 -567 78.3 -192 0.0 0.0   Pre-tax profit (PTP)   -216.0 -160.0 254.6 -653.1 75.3 -199.1 0.0 0.0   Net earnings   -168.5 -125.3 198.6 -507.9 58.7 -155.3 0.0 0.0   Pre-tax profit without non-rec. items   -216 -160 255 -653 75.3 -199 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 95.4 163 274 237 145 0.0 0.0   Shareholders equity total   -221 -346 -148 50.0 109 50.0 0.0 0.0   Interest-bearing liabilities   376 608 795 1,709 4.8 115 0.0 0.0   Balance sheet total (assets)   167 322 714 1,774 421 205 0.0 0.0   Net Debt   364 608 750 1,553 4.8 115 -0.0 -0.0     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -216 -139 320 -506 115 -170 0.0 0.0   Gross profit growth   -67.3% 35.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employees               0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   167 322 714 1,774 421 205 0 0   Balance sheet change%   72.5% 92.2% 122.0% 148.6% -76.2% -51.5% -100.0% 0.0%   Added value   -215.7 -139.0 319.8 -505.6 139.9 -170.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 92 30 49 -73 -114 -145 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 -3.0 1.0 -1.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 102.4% 88.3% 112.2% 68.2% 112.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -80.3% -26.9% 37.0% -43.0% 7.1% -61.3% 0.0% 0.0%   ROI %   -83.6% -28.8% 39.9% -44.1% 8.3% -124.4% 0.0% 0.0%   ROE %   -127.5% -51.3% 38.4% -133.0% 74.0% -195.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -56.9% -51.8% -17.1% 2.8% 25.8% 24.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -168.9% -437.3% 234.5% -307.2% 4.2% -67.8% 0.0% 0.0%   Gearing %   -170.1% -175.6% -539.1% 3,418.9% 4.4% 231.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.1% 3.6% 4.0% 6.9% 0.4% 12.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 0.1 0.1 0.3 0.1 0.4 0.0 0.0   Current Ratio   0.4 0.3 0.6 0.9 0.6 0.4 0.0 0.0   Cash and cash equivalent   11.1 0.2 45.4 156.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -220.8 -436.9 -304.3 -214.2 -114.2 -80.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -2,157 -1,390 3,198 -5,056 1,399 -1,704 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -2,157 -1,390 3,198 -5,056 1,149 -1,704 0 0   EBIT / employee   -2,157 -1,423 2,825 -5,672 783 -1,918 0 0   Net earnings / employee   -1,685 -1,253 1,986 -5,079 587 -1,553 0 0